MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corp (OCBB: RMCP) has begun the selection process for a manufacturer of its proprietary Rev Vac safety syringe. The FDA 510K lab testing and application for its safety syringe will be finished soon, and enter the FDA fast track program. Revolutions Medical is taking the next step to bring its first product to the market. The company has already identified numerous manufacturing facilities and will start a stringent selection process which includes but not limited to capacity, quality assurances, costs and delivery scheduling.
